CAS: | 1315330-17-6 | ||
分子式: | C32H34F3N5O4 | ||
分子量: | 609.64 | ||
英文名称: |
|
货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||
D727170 | MACKLIN | 3-((6,7-二甲氧基喹唑啉-4-基)氧基)-N-(4-((4-乙基哌嗪-1-基)甲基)-3-(三氟甲基)苯基)-4-甲基苯甲酰胺 | 99% | 179元/1mg; 451元/5mg; 675元/10mg; | 展开 | ||||||||||||||||||||||||||||||
储存:2-8°C, 干燥 | |||||||||||||||||||||||||||||||||||
SML3202 | Sigma-Aldrich | TL02-59 | ≥98% (HPLC) | 978.44元/5 MG; 3943.82元/25 MG; | 展开 | ||||||||||||||||||||||||||||||
产品说明 生化/生理作用 TL02-59 is a potent inhibitor of Fgr kinase, a Src-family kinase expressed in myeloid cells and associated with acute myelogenous leukemia (AML). It exhibited an IC50 value of 0.03 nM for Fgr, 0.10 nM for related Src-family kinase Lyn, with >1000-fold less potency for all other kinases tested. TL02-59 given orally in a mouse xenograft model of AML was able to eliminate spleen and peripheral blood leukemic cells and significantly reduce bone marrow engraftment. 基本信息
产品性质
安全信息
|